Molecular diagnostics company focused on early cancer detection and targeted treatment
Molecular diagnostics company focused on early cancer detection and targeted treatment. Its LiquidBiopsy system analyzes tumor cell-associated mutations from a blood draw to support real-time monitoring, treatment selection, clinical-trial enrollment, and assessment of patient response. The company later changed its name to LungLife AI Inc.